Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04337931
Title A Study to Evaluate APX005M in Subjects With Unresectable or Metastatic Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Apexigen, Inc.
Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.